Nov 30, 2021 | Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NASDAQ: FENC) violated federal securities laws or engaged in other unlawful business practices.
FENNEC INVESTORS WITH FINANCIAL LOSSES GREATER THAN $25,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE.
On November 29, 2021, Fennec reported that “. . . it expects the U.S. Food and Drug Administration will not accept the company’s New Drug Application for PEDMARK™.”
The Company also stated that “. . . it expects to receive a Complete Response Letter (CRL) after the PDUFA target action date of November 27, 2021 from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for PEDMARKTM (a unique formulation of sodium thiosulfate), for intravenous administration for the prevention of ototoxicity associated with cisplatin chemotherapy in pediatric patients ≥1 month to 18 years of age with localized, non-metastatic, solid tumors.”
Further, Fennec reported that “[t]he FDA has indicated that, following a recent completion of a pre-approval inspection of the manufacturing facility of our drug product manufacturer, deficiencies have been identified.”
On this news, shares of Fennec declined $4.86 per share on November 29, 2021, thereby injuring investors. During intraday trading on November 30, 2021, Fennec shares were down more than 6%.
FENNEC INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES AND LOST MORE THAN $25,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE FENNEC SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Nov 24, 2021 | Shareholder Investigations
DocGo Investors Who Have Suffered Losses Greater Than $50,000 Are Encouraged To Contact Kehoe Law Firm, P.C. – Securities Class Action Investigation
Kehoe Law Firm, P.C. is investigating whether DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) violated federal securities laws or engaged in other unlawful business practices.
In a Form 8-K recently filed with the SEC, DocGo reported that “. . . on November 22, 2021, the Company’s management and the audit committee of the Company’s board of directors . . . concluded that the Company’s previously issued (i) audited balance sheet as of October 19, 2020 (the ‘Post-IPO Balance Sheet’), as previously revised in [Motion Acquisition Corp.’s] Annual Report on Form 10-K, as amended, for the fiscal year ended December 31, 2020, filed with the SEC on May 28, 2021 (‘2020 Form 10-K/A No. 1’), (ii) audited financial statements included in the 2020 Form 10-K/A No. 1, (iii) unaudited interim financial statements included in Motion’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021, filed with the SEC on June 3, 2021, (iv) unaudited interim financial statements included in Motion’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed with the SEC on August 11, 2021 and (v) unaudited interim financial statements included in Motion’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the SEC on November 15, 2021 (collectively, the ‘Affected Periods’), should be restated to report all Public Shares as temporary equity and should no longer be relied upon.” [Emphasis added.]
DocGo also stated that “[a]s such, the Company intends to restate the financial statements for the Affected Periods in a Form 10-K/A to be filed with the SEC for the Post-IPO Balance Sheet and Motion’s audited financial statements included in the 2020 Form 10-K/A No. 1 (the ‘Form 10-K/A No. 2’) and the unaudited condensed financial statements for the periods ended March 31, 2021, June 30, 2021, and September 30, 2021 in Motion’s Amendment No. 1 to the Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, to be filed with the SEC (the ‘Q3 Form 10-Q/A No. 1’).”
On this news, DocGo’s stock price declined significantly. DocGo’s stock closed down more than 4% on November 23, 2021, further injuring investors.
DOCGO INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE DOCGO SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
This press release may constitute attorney advertising.
Nov 18, 2021 | Shareholder Investigations
Standard Lithium Investors Who Have Suffered Losses Greater Than $50,000 Are Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating whether Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (NYSE: SLI) violated federal securities laws or engaged in other unlawful business practices.
Standard Lithium investors should be aware that on November 18, 2021, Seeking Alpha reported that Blue Orca Capital issued a short report which “. . . claims that Standard Lithium is ‘massively overvalued’ and that data it has uncovered indicates the ‘actual recovery rate’ from an Arkansas facility is ‘magnitudes lower’ than what the company asserts.”
On this news, shares of Standard Lithium stock were down more than 18% during intraday trading on November 18, 2021.
STANDARD LITHIUM INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Nov 9, 2021 | Shareholder Investigations
Cronos Group Investors With Losses Greater Than $25,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating whether Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) violated federal securities laws.
Cronos investors should be aware that Cronos filed a Form 8-K, dated November 9, 2021, which stated that “[o]n November 8, 2021, Cronos Group Inc. . . . determined that it will be required to restate its previously issued unaudited interim financial statements for the three and six months ended June 30, 2021 previously filed on Form 10-Q on August 6, 2021.”
Cronos reported that “[t]he Company’s financial statements for this period should therefore no longer be relied upon.”
Cronos also reported that “. . . the Company concluded that it should have recorded an impairment charge of not less than $220 million on goodwill and indefinite-lived intangible assets in its U.S. reporting unit for the three and six months ended June 30, 2021. The Company will restate its unaudited interim financial statements for the three and six months ended June 30, 2021, accordingly.” According to Cronos, it “. . . is also evaluating whether to record an additional impairment in the three and nine months ended September 30, 2021.”
Cronos stock was down more than 15% during intraday trading on November 9, 2021, thereby injuring investors.
CRONOS INVESTORS THAT ACQUIRED THE COMPANY’S STOCK AND SUFFERED LOSSES GREATER THAN $25,000 WHO WISH TO DISCUSS KEHOE LAW FIRM’S SECURITIES CLASS ACTION INVESTIGATION OR HAVE QUESTIONS ABOUT POTENTIAL LEGAL CLAIMS ARE ENCOURAGED TO COMPLETE THE FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT EITHER JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected].
Nov 4, 2021 | Shareholder Investigations
Seer Investors With Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential class action securities claims on behalf of investors of Seer, Inc. (“Seer” or the “Company”) (NASDAQ: SEER) to determine whether Seer engaged in securities fraud or other unlawful business practices.
On November 4, 2021, Seeking Alpha reported that “Seer Inc. . . . dropped 7% after a new short call from The Bear Cave.” Seeking Alpha reported that “[t]he Bear Cave claims that the company appears to be a ‘promotional and misleading’ biotech company.”
On this news, shares of Seer stock dropped, thereby injuring investors.
SEER INVESTORS WHO HAVE SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT EITHER JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Nov 4, 2021 | Shareholder Investigations
Investors Who Acquired Baidu Securities Between March 22, 2021 And March 29, 2021 Are Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of shareholders of Baidu, Inc. (“Baidu” or the “Company”) (NASDAQ: BIDU).
The securities investigation concerns the trading by Goldman Sachs and Morgan Stanley in late March 2021 and whether those investment banks traded on material, non-public information by selling large amounts of Baidu stock based on information obtained through their relationship with Archegos Capital Management. The investigation also focuses on whether both banks avoided billions of dollars of losses by selling before the information was publicly available.
Shares of Baidu stock fell significantly during the week of March 22, 2021 to March 29, 2021, thereby injuring investors.
BAIDU INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES BETWEEN MARCH 22, 2021 AND MARCH 29, 2021 WHO WISH TO DISCUSS KEHOE LAW FIRM’S SECURITIES CLASS ACTION INVESTIGATION OR HAVE QUESTIONS ABOUT POTENTIAL LEGAL CLAIMS ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT EITHER JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected].
